LD score regression39 was used to determine if any traits were correlated with CRC risk. GWAS summary data were obtained for allergy, asthma, coronary artery disease, fatty acids, lipids (total cholesterol, high density lipoprotein, low-density lipoprotein, triglycerides), auto-immune diseases (Crohn’s disease, rheumatoid arthritis, atopic dermatitis, celiac disease, multiple sclerosis, primary biliary cirrhosis, inflammatory bowel disease, ulcerative colitis, systemic lupus erythematosus), anthropometric measures (BMI, height, body fat), glucose sensitivity (fasting glucose, fasting insulin, HbA1c), childhood measures (birth weight, birth length, childhood obesity, childhood BMI), eGFR and type 2 diabetes. All data were obtained for European populations. Summary statistics were reformatted to be consistent, and constrained to HapMap3 SNPs as these have been found to generally impute well. LD Scores were determined using 1000 Genomes European data.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.